Prostate Cancer
Conditions
Brief summary
The development of a personalized therapeutic education program dedicated to patients with metastatic prostate cancer and receiving next-generation hormone therapy would improve their knowledge of the disease, medication adherence and quality of life.
Interventions
OTHERFocus group creation
Patients will join with researchers for a 2 hour recorded group discussion to highlight themes identified to require educational intervention
OTHERWorkshop
Patients will attend 3-4 workshops on eg disease knowledge, medication management and side effects, adapted physical activity and nutrition
Sponsors
Centre Hospitalier Universitaire de Nīmes
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients with metastatic prostate cancer treated with enzalutamide or abiraterone acetate for at least 3 months * The patient must have given their free and informed consent and signed the consent form * The patient must be insured or the beneficiary of an insurance policy
Exclusion criteria
* The subject is not in a fit state to express their consent * It is impossible to give the subject informed information * The patient is under safeguard of justice or state guardianship
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Patient satisfaction | End of workshops (max 2 months) | Yes/no |
| Successful running of workshop | End of workshops (max 2 months) | Yes/no evaluated by the workshop leader |
| Create a focus group | Day 0 | Transcribe interview and mark key points |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Patient-reported acceptability of programme | End of workshops (max 2 months) | In-house questionnaire: 4 questions on 0-5 scale unacceptable to very acceptable and 4 open questions |
| Patient medication adherence | End of workshops (max 2 months) | MMAS-9 questionnaire: good adherence is score = 8 |
| Patient-reported satisfaction of programme | End of workshops (max 2 months) | In-house questionnaire: 5 questions on 0-5 scale unsatisfied to very satisfied |
| Patient participation rate in workshops | End of workshops (max 2 months) | % |
| Patient knowledge of their disease | End of workshops (max 2 months) | In-house quiz: 7 multiple-choice questions |
| Patient quality of life | 1 month after last workshop | EQ-5D-3L |
Countries
France
Contacts
PRINCIPAL_INVESTIGATORNadine Houede
CHU Nimes
Outcome results
None listed